Baxter International Inc. vs. Integra LifeSciences Holdings
Baxter International Inc. (BAX) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BAX | IART | |
|---|---|---|
| Market Cap | $12.22 billion | $1.25 billion |
| Revenue (TTM) | — | $1.65 billion |
| Net Income (TTM) | — | $-7,242,000 |
BAX leads on 1 of 1 size & scale factors.
Valuation
| BAX | IART | |
|---|---|---|
| Price / Book | — | 1.20 |
| Price / Sales | — | 0.76 |
BAX and IART split the valuation factors evenly.
Profitability
| BAX | IART | |
|---|---|---|
| Net Margin | — | -0.44% |
| Return on Equity | — | -0.69% |
BAX and IART split the profitability factors evenly.
Dividend
| BAX | IART | |
|---|---|---|
| Dividend Yield | 0.17% | — |
BAX and IART split the dividend factors evenly.
Risk & Sentiment
| BAX | IART | |
|---|---|---|
| Short Interest | 1.03% | 6.92% |
BAX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, IART overview, IART financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.